<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24658118</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.</ArticleTitle><Pagination><StartPage>e92495</StartPage><MedlinePgn>e92495</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e92495</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0092495</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Infection with dengue virus (DENV) may cause life-threatening disease with thrombocytopenia and vascular leakage which are related to dysfunction of platelets and endothelial cells. We previously showed that antibodies (Abs) against DENV nonstructural protein 1 (NS1) cross-react with human platelets and endothelial cells, leading to functional disturbances. Based on sequence homology analysis, the C-terminal region of DENV NS1 protein contains cross-reactive epitopes. For safety in vaccine development, the cross-reactive epitopes of DENV NS1 protein should be deleted or modified.</AbstractText><AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">We tested the protective effects of Abs against full-length DENV NS1, NS1 lacking the C-terminal amino acids (a.a.) 271-352 (designated &#x394;C NS1), and chimeric DJ NS1 consisting of N-terminal DENV NS1 (a.a. 1-270) and C-terminal Japanese encephalitis virus NS1 (a.a. 271-352). The anti-&#x394;C NS1 and anti-DJ NS1 Abs showed a lower binding activity to endothelial cells and platelets than that of anti-DENV NS1 Abs. Passive immunization with anti-&#x394;C NS1 and anti-DJ NS1 Abs reduced DENV-induced prolonged mouse tail bleeding time. Treatment with anti-DENV NS1, anti-&#x394;C NS1 and anti-DJ NS1 Abs reduced local skin hemorrhage, controlled the viral load of DENV infection in vivo, synergized with complement to inhibit viral replication in vitro, as well as abolished DENV-induced macrophage infiltration to the site of skin inoculation. Moreover, active immunization with modified NS1 protein, but not with unmodified DENV NS1 protein, reduced DENV-induced prolonged bleeding time, local skin hemorrhage, and viral load.</AbstractText><AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">These results support the idea that modified NS1 proteins may represent an improved strategy for safe and effective vaccine development against DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Shu-Wen</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yi-Tien</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chia-Hui</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hsiao-Sheng</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Trai-Ming</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Yu-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu-Hsieh</LastName><ForeName>Betty A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C079340">NS1 protein, Dengue virus type 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24658118</ArticleId><ArticleId IdType="pmc">PMC3962419</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0092495</ArticleId><ArticleId IdType="pii">PONE-D-13-45193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distrubution and burden of dengue. Nature 496: 504&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons CP, Farrar JJ, Nguyen vV, Wills B (2012) Dengue. N Engl J Med 366: 1423&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB (2007) Dengue. Lancet 370: 1644&#x2013;1652.</Citation><ArticleIdList><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>Yauch LE, Shresta S (2008) Mouse models of dengue virus infection and disease. Antiviral Res 80: 87&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3048811</ArticleId><ArticleId IdType="pubmed">18619493</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA (2007) Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81: 5518&#x2013;5526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900309</ArticleId><ArticleId IdType="pubmed">17360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen YT, Chen HC, Lin YD, Shieh CC, Wu-Hsieh BA (2008) Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol 82: 12312&#x2013;12324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2593312</ArticleId><ArticleId IdType="pubmed">18842737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu-Hsieh BA, Yen YT, Chen HC (2009) Dengue hemorrhage in a mouse model. Ann N Y Acad Sci 1171 Suppl 1E42&#x2013;E47.</Citation><ArticleIdList><ArticleId IdType="pubmed">19751401</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB (1998) Pathogenesis of dengue: challenges to molecular biology. Science 239: 476&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM (1994) Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 19: 500&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pubmed">7811870</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB (2002) Dengue. Curr Opin Infect Dis 15: 471&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">12686878</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">14689700</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, et al. (2006) The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol 176: 2825&#x2013;2832.</Citation><ArticleIdList><ArticleId IdType="pubmed">16493039</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ (2007) Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 104: 9422&#x2013;9427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868655</ArticleId><ArticleId IdType="pubmed">17517625</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, et al. (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6: e1000790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820409</ArticleId><ArticleId IdType="pubmed">20168989</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger JJ, Brandriss MW, Walsh EE (1987) Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 68 (Pt 3): 853&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">3819700</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim JH, Diniz MO, Cariri FA, Rodrigues JF, Bizerra RS, et al. (2012) Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine 30: 837&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">22178517</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal EA, Henchal LS, Schlesinger JJ (1998) Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol 69 (Pt 8): 2101&#x2013;2107.</Citation><ArticleIdList><ArticleId IdType="pubmed">3404125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SF, Liao C L, Lin YL, Yeh CT, Chen LK, et al. (2003) Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21: 3919&#x2013;3929.</Citation><ArticleIdList><ArticleId IdType="pubmed">12922127</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire MS, et al. (2007) DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 358: 413&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">17020777</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconar AK (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142: 897&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pubmed">9191856</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconar AK (2007) Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design. Clin Vaccine Immunol 14: 493&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1865631</ArticleId><ArticleId IdType="pubmed">17329445</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu IJ, Chiu CY, Chen YC, Wu HC (2011) Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem 286: 9726&#x2013;9736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058979</ArticleId><ArticleId IdType="pubmed">21233208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, et al. (2011) Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med 236: 515&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, et al. (2008) Patient and mouse antibodies against Dengue virus nonstructural protein 1 cross-react with platelets and cause their dysfunction or depletion. Am J Infect Dis 4: 69&#x2013;75.</Citation></Reference><Reference><Citation>Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, et al. (2002) Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol 169: 657&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pubmed">12097367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, et al. (2005) Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol 174: 395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">15611263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HJ, Lin CF, Lei HY, Liu HS, Yeh TM, et al. (2009) Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med 234: 63&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18997103</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, et al. (2009) Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J. Immunol 183: 1797&#x2013;1803.</Citation><ArticleIdList><ArticleId IdType="pubmed">19592650</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe9;verin S, Gratacap MP, Lenain N, Alvarez L, Hollande E, et al. (2007) Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 117: 944&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1810573</ArticleId><ArticleId IdType="pubmed">17347685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pubmed">1361507</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Li SY, Chen SC, Liu HS, Lin YS, et al. (2000) Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 81: 2177&#x2013;2182.</Citation><ArticleIdList><ArticleId IdType="pubmed">10950974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lin CF, Chen MC, Lei HY, Liu HS, et al. (2008) C-terminal region of dengue virus nonstructural protein 1 is involved in endothelial cell cross-reactivity via molecular mimicry. Am J Infect Dis 4: 85&#x2013;91.</Citation></Reference><Reference><Citation>Chuang YC, Lin YS, Liu HS, Wang JR, Yeh TM (2013) Antibodies against thrombin in dengue patients contain both anti-thrombotic and pro-fibrinolytic activities. Thromb Haemost 110: 358&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">23740201</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger JJ, Brandriss MW, Walsh EE (1985) Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol 135: 2805&#x2013;2809.</Citation><ArticleIdList><ArticleId IdType="pubmed">4031501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, et al. (1998) DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 72: 191&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109364</ArticleId><ArticleId IdType="pubmed">9420215</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna VD, Rangappa M, Satchidanandam V (2009) Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. J Virol 83: 4766&#x2013;4777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682061</ArticleId><ArticleId IdType="pubmed">19264772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitai Y, Kondo T, Konishi E (2010) Complement-dependent cytotoxicity assay for differentiating West Nile virus from Japanese encephalitis virus infections in horses. Clin Vaccine Immunol 17: 875&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863385</ArticleId><ArticleId IdType="pubmed">20237201</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R, Wang S, Osiowy C, Issekutz AC (1997) Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 71: 4226&#x2013;4232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191637</ArticleId><ArticleId IdType="pubmed">9151809</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger JJ, Foltzer M, Chapman S (1993) The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192: 132&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">8517015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CW, Liu KT, Huang HD, Chen WJ (2008) Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus. Biotechnol Lett 30: 205&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">17876533</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, et al. (2006) Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol 80: 1340&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346945</ArticleId><ArticleId IdType="pubmed">16415011</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Pierson TC, Fremont DH (2008) The structural immunology of antibody protection against West Nile virus. Immunol Rev 225: 212&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646609</ArticleId><ArticleId IdType="pubmed">18837784</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgout B, Bray M, Schlesinger JJ, Lai CJ (1990) Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol 64: 4356&#x2013;4363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247903</ArticleId><ArticleId IdType="pubmed">2143542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KM, Thompson BS, Fremont DH, Diamond MS (2007) Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. J Virol 81: 9551&#x2013;9555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951387</ArticleId><ArticleId IdType="pubmed">17582005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HJ, Lei HY, Lin CF, Luo YH, Wan SW, et al. (2009) Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol Immunol 47: 398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">19822367</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz FX, Stiasny K (2012) Flaviviruses and flavivirus vaccines. Vaccine 30: 4301&#x2013;4306.</Citation><ArticleIdList><ArticleId IdType="pubmed">22682286</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan S, Batra G, Khanna N (2010) Dengue vaccines: state of the art. Expert Opin Ther Pat 20: 819&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pubmed">20384534</ArticleId></ArticleIdList></Reference><Reference><Citation>Coller BA, Clements DE (2011) Dengue vaccines: progress and challenges. Curr Opin Immunol 23: 391&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">21514129</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrell S, Wu SC, Butler M (2011) Review of dengue virus and the development of a vaccine. Biotechnol Adv 29: 239&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">21146601</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SJ, Endy TP (2011) Critical issues in dengue vaccine development. Curr Opin Infect Dis 24: 442&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">21799408</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng GC, Lei HY, Lin YS, Chokephaibulkit K (2011) Dengue vaccines: challenge and confrontation. World J Vaccines 1: 109&#x2013;130.</Citation></Reference><Reference><Citation>Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, et al. (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 380: 1559&#x2013;1567.</Citation><ArticleIdList><ArticleId IdType="pubmed">22975340</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh EP, Kukkaro P, Teo EW, Lim APC, Tan TT, et al. (2012) The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med 4: 139ra83.</Citation><ArticleIdList><ArticleId IdType="pubmed">22723463</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PC, Liao MY, Cheng PC, Liang JJ, Liu IJ, et al. (2012) Development of a humanized antibody with high therapeutic potential against dengue virus type 2. PLoS Negl Trop Dis 6: e1636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341331</ArticleId><ArticleId IdType="pubmed">22563515</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques HR, Rampazo EV, Gon&#xe7;alves AJS, Vicentin ECM, Amorim JH, et al. (2013) Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl Trop Dis 7: e2330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715404</ArticleId><ArticleId IdType="pubmed">23875054</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>